Leslie Lehmann, MD
Disclosures: Nothing to disclose

Dr. Lehmann attended Harvard College and received her MD from Duke University Medical School, where, after finishing a pediatric residency, she spent a year as chief resident. She completed a pediatric hematology-oncology fellowship at DFCI/Children's Hospital Boston in 1996 and subsequently joined the faculty.  In 1998, she became Medical Director of the Pediatric Transplant Unit at Children's Hospital and, in 2007, was appointed Clinical Director of the Pediatric Stem Cell Transplant Program. She has a long-standing interest in global health and has worked closely with pediatric oncology programs in Cairo, Baghdad, Mexico and Rwanda. In 2016, she became the Medical Director of the Dana Farber/Boston Children’s Hospital Global Health Initiative. Currently, she is an Assistant professor in the Division of Hematopoietic Stem Cell Transplantation at Dana Farber Cancer Institute/Boston Children’s Hospital. The overall focus of her research is on complications of transplantation including resource utilization (hospital readmissions) and viral reactivation.